Cryo-Cell International, Inc.

NYSE American:CCEL

Market Cap

USD 39.20 M

Share Price

USD 4.80

Avg Daily Volume

11,770

Change (1 day)

-1.03%

Change (1 year)

-33.52%

Change (YTD)

-35.22%

Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending February 28, 2025: 8.68%

Cryo-Cell International, Inc. EBIT Margin is 8.68% for the Trailing 12 Months (TTM) ending February 28, 2025, a -123.31% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending February 29, 2024 was -37.22%, a -358.78% change year over year.
  • Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending February 28, 2023 was 14.38%, a -0.17% change year over year.
  • Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending February 28, 2022 was 14.41%, a -32.76% change year over year.
  • Cryo-Cell International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending February 28, 2021 was 21.43%, a 24.32% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin